Skip to content
Review Open access

Early Right Heart Failure After Left Ventricular Assist Device Implantation: A Narrative Review of Definitions, Risk Prediction, and Management

Jan 2026 · Cardiovascular Therapeutics · Vol 2026 · 0 citations · 46 references
Medicine

TL;DR

No single clinical, imaging, or hemodynamic measure reliably predicts early RHF, and existing scores perform variably on external validation, so management begins by addressing reversible causes and optimizing LVAD support.

Abstract

Early right heart failure (RHF) remains common after left ventricular assist device (LVAD) implantation and is associated with substantial morbidity and mortality. Definition and time window determine reported incidence and complicate risk‐model comparison. Established risk models perform differently across cohorts and device eras, and temporary support should be matched to the dominant physiology. LV unloading alters venous return, septal geometry, and right ventricular (RV) loading, whereas perioperative stress exposes limited RV reserve. No single clinical, imaging, or hemodynamic measure reliably predicts early RHF, and existing scores perform variably on external validation. Dynamic hemodynamic assessment adds information about RV reserve and warrants prospective threshold validation. Management begins by addressing reversible causes and optimizing LVAD support. When temporary mechanical support is required, RV‐specific bypass restores pulmonary forward flow, an oxygenated right atrial‐to‐pulmonary arterial RVAD adds gas exchange, and venoarterial extracorporeal membrane oxygenation provides broader rescue for combined circulatory and respiratory failure. Comparative evidence on timing and configuration remains observational.

Read PDF

Similar papers

Open access Sep 2026

Predicting the right! Validation of right heart failure predictive risk models after primary durable ventricular assist device implantation

Objectives Perioperative right heart failure remains a severe complication after durable left ventricular assist device implantation. Accurate preoperative risk assessment is crucial to identify patients requiring advanced medical or mechanical biventricular support. Existing predictive risk models show limited compara...

M. Sales, R. Zayat, N. Hatam et al. · 1 citation
Open access Sep 2026

Assessment of the predictive value of right ventricular longitudinal strain and functional trends in right ventricular function of patients after LVAD implantation

Right heart failure (RHF) remains a major determinant of morbidity and mortality following left ventricular assist device (LVAD) implantation. Right ventricular free wall strain (RVFWS) and global longitudinal strain (RVGLS) have emerged as promising echocardiographic markers, yet their long-term prognostic utility and...

C. Braun, R. Schramm, M. Morshuis et al. · 0 citations
Oct 2026

Left Ventricular Functional Improvement is Associated With Lower Morbidity and Mortality During Long-Term Mechanical Circulatory Support: An STS Intermacs Analysis.

BACKGROUND A subset of patients with advanced heart failure (HF) supported with durable left ventricular assist devices (LVADs) demonstrate significant improvement in left ventricular ejection fraction (LVEF), but the impact of such functional improvement on clinical outcomes is unclear. METHODS We analyzed adults in...

E. Maneta, I. Kyriakoulis, C. Kyriakopoulos et al. · 0 citations
Open access Oct 2026

Pulmonary arterial elastance after LVAD implantation as a predictor of late right ventricular failure beyond six months of support

Late right ventricular failure (LRVF)—either de novo beyond the early postoperative period or persistent from earlier phases—remains a major complication after left ventricular assist device (LVAD) implantation and is associated with increased morbidity and mortality compared with resolved early RVF. The right ve...

E. Karapedi, J. G. Bofarull, G. Gallone et al. · 0 citations
Review Open access Oct 2026

Clinically Actionable Prevention and Management of Major Complications During Durable Left Ventricular Assist Device Support: A Contemporary Narrative Review

Durable left ventricular assist devices (LVADs) have become an established therapy for selected patients with advanced heart failure as bridge-to-transplant or destination therapy. Despite major progress in continuous-flow pump design and perioperative care, long-term benefit remains constrained by a recurrent burden o...

Wei-Yong Sheng, Tian-Sheng Tang, You-Shi Wu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.